Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/Ya Tsie trial

Magosi LE. et al, (2022), eLife, 11

A highly virulent variant of HIV-1 circulating in the Netherlands

Wymant C. et al, (2022), Science, 375, 540 - 545

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

Twohig KA. et al, (2022), The Lancet Infectious Diseases, 22, 35 - 42

Many but small HIV-1 non-B transmission chains in the Netherlands.

Bezemer D. et al, (2022), AIDS (London, England), 36, 83 - 94

Publisher Correction: Monitoring key epidemiological parameters of SARS-CoV-2 transmission

Kraemer MUG. et al, (2022), Nature Medicine, 28, 213 - 213

Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial

Limbada M. et al, (2022), The Lancet HIV, 9, e13 - e23

Context-specific emergence and growth of the SARS-CoV-2 Delta variant

McCrone JT. et al, (2021)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Clemens SAC. et al, (2021), Nature Communications, 12

Modeling the effect of exposure notification and non-pharmaceutical interventions on COVID-19 transmission in Washington state

Abueg M. et al, (2021), npj Digital Medicine, 4

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.

Elliott P. et al, (2021), Science (New York, N.Y.)

Monitoring key epidemiological parameters of SARS-CoV-2 transmission

Kraemer MUG. et al, (2021), Nature Medicine, 27, 1854 - 1855

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

de Silva TI. et al, (2021), iScience, 24, 103353 - 103353

Improving Post-Release Care Engagement for People Living with HIV Involved in the Criminal Justice System: A Systematic Review

Moher M. et al, (2021), AIDS and Behavior

Demographic characteristics of sources of HIV-1 transmission in Zambia

Hall M. et al, (2021)

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Abdukahil SA. et al, (2021), Infection, 49, 889 - 905

PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial.

Pickles M. et al, (2021), PLoS computational biology, 17

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil; an exploratory analysis of a randomised controlled trial

Clemens SC. et al, (2021)

OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.

Hinch R. et al, (2021), PLoS computational biology, 17

Age patterns of HIV incidence in eastern and southern Africa: a modelling analysis of observational population-based cohort studies.

Risher KA. et al, (2021), The lancet. HIV, 8, e429 - e439

The epidemiological impact of the NHS COVID-19 app

Wymant C. et al, (2021), Nature, 594, 408 - 412

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?